Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows from Operating Activities
Net (loss) income	$ (17,097,000)	$ 2,835,000
Non-cash items included in net income
Depreciation and amortization	5,124,000	3,605,000
Deferred income taxes	(5,667,000)	(962,000)
Impairment of goodwill	28,000,000
Deferred compensation plan	(413,000)	237,000
Stock compensation expense	1,463,000	1,688,000
Issuance of common shares as compensation	156,000	228,000
Loss (gain) on disposition of fixed assets	(29,000)	53,000
Fixed asset impairment and accelerated depreciation		354,000
Allowance for doubtful accounts	115,000	205,000
Inventory obsolescence reserve	1,033,000	758,000
Changes in certain assets and liabilities:
Accounts receivable	(10,975,000)	(2,771,000)
Inventories	313,000	979,000
Refundable income taxes	775,000
Accounts payable	(2,626,000)	(176,000)
Accrued expenses and other	(742,000)	(2,630,000)
Customer prepayments	(221,000)	216,000
Net cash flows (used in) provided by operating activities	(791,000)	4,619,000
Cash Flows from Investing Activities
Purchases of property, plant and equipment	(1,190,000)	(2,744,000)
Proceeds from sale of fixed assets	1,527,000	1,000
Net cash flows provided by (used in) investing activities	337,000	(2,743,000)
Cash Flows from Financing Activities
Payments of long-term debt	(48,553,000)
Borrowings of long-term debt	51,004,000
Cash dividends paid	(2,564,000)	(2,513,000)
Exercise of stock options	174,965	295,030
Purchase of treasury shares	(107,000)	(390,000)
Acquisition of common stock for tax withholding related to share based compensation	183,000
Issuance of treasury shares	454,000	44,000
Net cash flows provided by (used in) financing activities	592,000	(2,688,000)
Increase (decrease) in cash and cash equivalents	138,000	(812,000)
Cash and cash equivalents at beginning of period	3,039,000	33,835,000
Cash and cash equivalents at end of period	$ 3,177,000	$ 33,023,000